BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1699775)

  • 1. Secretion of tumor necrosis factor-alpha by fresh human acute nonlymphoblastic leukemic cells: role in the disappearance of normal CFU-GM progenitors.
    Kobari L; Weil D; Lemoine FM; Dubois C; Thiam D; Baillou C; Guigon M; Gorin NC; Najman A
    Exp Hematol; 1990 Dec; 18(11):1187-92. PubMed ID: 1699775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.
    Roodman GD; Bird A; Hutzler D; Montgomery W
    Exp Hematol; 1987 Oct; 15(9):928-35. PubMed ID: 2820776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of methylcellulose on colony growth of human myeloid leukemic progenitors (AML-CFU).
    Allieri MA; Douay L; Deloux J; Smadja N; Najman A; Gorin NC
    Exp Hematol; 1990 Sep; 18(8):911-5. PubMed ID: 2387341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tumor necrosis factor-alpha on normal feline hematopoietic progenitor cells.
    Khan KN; Kociba GJ; Wellman ML; Reiter JA
    Exp Hematol; 1992 Aug; 20(7):900-3. PubMed ID: 1321052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement by transforming growth factor-beta 1 (TGF-beta 1) of the proliferation of leukemic blast progenitors stimulated with IL-3.
    Suzuki T; Bessho M; Hirashima K; Tohda S; Nagata K; Morio T; Imai Y; Nara N
    J Cell Physiol; 1991 Sep; 148(3):396-403. PubMed ID: 1717497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
    Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
    J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
    Lagneaux L; Marie JP; Delforge A; Socquet M; Thevenin D; Zittoun R; Stryckmans P
    Exp Hematol; 1989 Aug; 17(7):843-6. PubMed ID: 2753092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
    Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vesnarinone, a quinolinone derivative, on the growth of leukemic blasts in acute myelogenous leukemia.
    Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
    Exp Hematol; 1997 Mar; 25(3):199-204. PubMed ID: 9091294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
    Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
    Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
    Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
    J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of recombinant human tumor necrosis factor (rh-TNF alpha) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukaemic blasts (CFU-L) in cultures in vitro.
    Robak T; Korycka A; Góra-Tybor J; Piotrowska-Wrzesień A; Krykowski E
    Arch Immunol Ther Exp (Warsz); 1992; 40(5-6):339-43. PubMed ID: 1340192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human granulocyte-macrophage colony formation by interleukin 2-treated lymphocytes is mediated by interferon gamma and tumor necrosis factor alpha.
    Takahashi M; Oshimi K; Mizoguchi H
    Exp Hematol; 1990 Jun; 18(5):395-9. PubMed ID: 2110909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human tumor necrosis factors alpha and beta stimulate fibroblasts to produce hemopoietic growth factors in vitro.
    Zucali JR; Broxmeyer HE; Gross MA; Dinarello CA
    J Immunol; 1988 Feb; 140(3):840-4. PubMed ID: 3276782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute lymphoblastic leukemia blast cells do not inhibit bone marrow hematopoietic progenitor colony formation.
    Estrov Z; Freedman MH
    Exp Hematol; 1991 Mar; 19(3):221-5. PubMed ID: 1995313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors.
    Piacibello W; Ferrero D; Sanavio F; Badoni R; Stacchini A; Severino A; Aglietta M
    Exp Hematol; 1991 Dec; 19(11):1084-9. PubMed ID: 1752317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.